Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MKKGY

Merck KGaA (PK) (MKKGY)

Merck KGaA (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:MKKGY
DateTimeSourceHeadlineSymbolCompany
07/12/202300:20Dow Jones NewsTrending: Merck's Multiple Sclerosis Drug Misses Expectations in Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
06/12/202321:14Dow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
06/12/202317:37Dow Jones NewsMerck MS Drug Fails to Meet Target of Late-Stage TrialsUSOTC:MKKGYMerck KGaA (PK)
05/12/202301:09Dow Jones NewsMerck to Pay at Least $70 Million for Rights to Abbisko Joint-Tumor DrugUSOTC:MKKGYMerck KGaA (PK)
09/11/202317:54Dow Jones NewsMerck KGaA Sees Earnings, Sales at Lower Half of Outlook RangesUSOTC:MKKGYMerck KGaA (PK)
06/11/202322:20Dow Jones NewsMerck KGaA Weighs Job Cuts at Electronics Division on Market DownturnUSOTC:MKKGYMerck KGaA (PK)
30/10/202319:59Dow Jones NewsMerck KGaA Enters Partnership With China's Hengrui for Up to $1.5 BillionUSOTC:MKKGYMerck KGaA (PK)
19/10/202319:22Dow Jones NewsMerck KGaA Shares Jump on Expected Return to Sales Growth in 2024USOTC:MKKGYMerck KGaA (PK)
19/10/202317:50Dow Jones NewsMerck KGaA Sees Return to Organic Sales Growth Next YearUSOTC:MKKGYMerck KGaA (PK)
20/09/202320:47Dow Jones NewsExscientia Shares Rally Premarket on Lucrative Merck DealUSOTC:MKKGYMerck KGaA (PK)
20/09/202316:05Dow Jones NewsMerck KGaA Enters Deal With BenevolentAI, Exscientia for AI-Based Drug DiscoveryUSOTC:MKKGYMerck KGaA (PK)
03/08/202315:55Dow Jones NewsMerck KGaA Cuts 2023 Outlook on Inventory, Semiconductor WoesUSOTC:MKKGYMerck KGaA (PK)
11/05/202315:46Dow Jones NewsMerck KgaA 1Q Earnings Hit by Lower Covid-19 Demand, Decline at Display SolutionsUSOTC:MKKGYMerck KGaA (PK)
08/05/202321:49Dow Jones NewsMerck KGaA Appoints Helene von Roeder as New CFOUSOTC:MKKGYMerck KGaA (PK)
13/04/202323:41Dow Jones NewsMerck KGaA Planning Sale of Surface Solutions Business, WirtschaftsWoche ReportsUSOTC:MKKGYMerck KGaA (PK)
12/04/202320:51Dow Jones NewsMerck KGaA to Invest $327 Million in Pennsylvania Site ExpansionUSOTC:MKKGYMerck KGaA (PK)
12/04/202317:54Dow Jones NewsMerck KGaA Shares Fall After US Puts Hold on New Patients in MS Drug TrialUSOTC:MKKGYMerck KGaA (PK)
02/03/202320:50Dow Jones NewsMerck KGaA Shares Fall After Warning of Challenges AheadUSOTC:MKKGYMerck KGaA (PK)
02/03/202317:44Dow Jones NewsMerck KGaA Sees Challenging 2023 After Rises in 2022 Earnings, SalesUSOTC:MKKGYMerck KGaA (PK)
22/11/202211:18Dow Jones NewsADRs End Mostly Lower, Naspers and Merck Trade ActivelyUSOTC:MKKGYMerck KGaA (PK)
22/11/202200:03Dow Jones NewsMerck KGaA Says It Plans One New Drug Launch Every One and a Half YearsUSOTC:MKKGYMerck KGaA (PK)
10/11/202218:04Dow Jones NewsMerck KGaA 3Q Sales, Earnings Rose; Fine-Tunes 2022 OutlookUSOTC:MKKGYMerck KGaA (PK)
20/10/202200:58Dow Jones NewsMerck KGaA's French Subsidiary Indicted in France Over Drug Formulation ChangeUSOTC:MKKGYMerck KGaA (PK)
19/10/202220:32Dow Jones NewsMerck KGaA's French Unit Under Further Investigations, AFP ReportsUSOTC:MKKGYMerck KGaA (PK)
06/10/202217:55Dow Jones NewsMerck KGaA Backs Mid-Term Targets; Plans Acquisitions as of 2023USOTC:MKKGYMerck KGaA (PK)
04/08/202216:06Dow Jones NewsMerck KGaA Earnings, Sales Grew in 2QUSOTC:MKKGYMerck KGaA (PK)
04/06/202200:21Dow Jones NewsMerck KGaA Discontinues Phase 2 Trial of Berzosertib in Combination With TopotecanUSOTC:MKKGYMerck KGaA (PK)
03/06/202202:38Dow Jones NewsProxygen Teams With Merck KGaA to Develop Molecular Glue DegradersUSOTC:MKKGYMerck KGaA (PK)
23/05/202219:53Dow Jones NewsMerck KGaA to Invest Around $465 Million to Expand Operations in IrelandUSOTC:MKKGYMerck KGaA (PK)
12/05/202215:31Dow Jones NewsMerck KGaA Expects Higher Profitability, Sales in 2022 After 1Q Earnings RiseUSOTC:MKKGYMerck KGaA (PK)
 Showing the most relevant articles for your search:USOTC:MKKGY